Bolt’s Ryan Breslow Is Backing This Male Birth Control Startup
ORIGINALLY POSTED ON Business Insider
JANUARY 2024
The market for male birth control is growing. One startup is touting a nonhormonal, long-lasting option — and thinks the tech could be ready for use in two years.
NEXT Life Sciences is taking a new approach with its male contraceptive called Plan A. The product uses Vasalgel, a hydrogel that blocks the flow of sperm through the vas deferens to prevent pregnancy.
This month, the startup landed fresh funding to power Plan A's first clinical trials, raising $2.5 million in seed funding led by Ryan Breslow's venture fund The Family, Business Insider has learned exclusively. Breslow, the founder of fintech startup Bolt, will now serve as a strategic advisor to NEXT.
NEXT's oversubscribed seed round included funding from entrepreneur Brock Pierce, Transform VC, StartupHealth, Pay It Forward Venture Capital, Particular Ventures, Keno Peer, Unpopular Ventures, and Joy Fund. The startup had raised $1.5 million in pre-seed funding in June.